Article
Genetic landscape of chronic myeloid leukemia.
International journal of hematology - 1 Jan 2023
Ochi Yotaro
Abstract excerpt
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by the BCR::ABL1 fusion gene, which aberrantly activates ABL1 kinase and promotes the overproduction of leukemic cells. CML typically develops in the chronic phase (CP) and progresses to a blast crisis (BC) after years without effective treatment. Although prognosis has substantially improved after the development of tyrosine kinase inhibitors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
